Form 4 for RMD ResMed|
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-25 · accession 0000943819-25-000181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-11-25 | RMD | De Witte Jan | Dir | S - Sale | $255.00 | -2,055 | 4,261 | -33% | -$524.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2025-11-25 | S | D | 2,055 | $255.00 | 4,261 | D | — | — |